Indication
Eosinophilic Granulomatosis With Polyangiitis
1 clinical trial
1 product
1 drug
Clinical trial
A RAndomised Placebo Controlled Trial - to Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With PolyangiitisStatus: , Estimated PCD: 2025-10-01
Product
TezepelumabDrug
Varlilumab